Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB06414_DB08870_nanopub.RAlg0Zg8ljpvOcU4iJbcU6e4zAtMKSa6V-hxuMn2GhdAU#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB06414_DB08870 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB06414_DB08870 label "DDI between Etravirine and Brentuximab vedotin - Brentuximab, when used concomitantly with etravirine, may experience a decrease in serum concentrations. The levels of an active metabolite of brentuximab, monomethyl auristatin E, may decrease. It is recommended to monitor efficacy of brentuximab therapy. [drugbank_resource:DB06414_DB08870]" assertion.
- drugbank_resource:DB06414_DB08870 identifier "drugbank_resource:DB06414_DB08870" assertion.
- drugbank_resource:DB06414_DB08870 title "DDI between Etravirine and Brentuximab vedotin - Brentuximab, when used concomitantly with etravirine, may experience a decrease in serum concentrations. The levels of an active metabolite of brentuximab, monomethyl auristatin E, may decrease. It is recommended to monitor efficacy of brentuximab therapy." assertion.
- drugbank:DB06414 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB06414_DB08870 assertion.
- drugbank:DB08870 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB06414_DB08870 assertion.